Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease

Eitemau Tebyg

• Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results From the CRISP Cohort
  gan: Boertien, Wendy E., et al.
  Cyhoeddwyd: (2012)
• Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
  gan: Meijer, Esther, et al.
  Cyhoeddwyd: (2010)
• Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
  gan: Zittema, Debbie, et al.
  Cyhoeddwyd: (2014)
• Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients
  gan: Heida, Judith E., et al.
  Cyhoeddwyd: (2021)
• Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
  gan: Messchendorp, A Lianne, et al.
  Cyhoeddwyd: (2019)